Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice
Authors:
Open Access
- 22 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 969962
Abstract
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease characterized by rapid progression and frequent comorbidities that make its treatment challenging. Nanomaterial-based strategies have been extensively studied to target the GI mucosal immune system in recent years. Herein, we propose a novel apigenin-Mn(II) loaded sodium hyaluronate nanoparticles where apigenin (API) was incorporated in the Mn2+ ramework, coated with hyaluronic acid. The apigenin-Mn(II) loaded sodium hyaluronate nanoparticles (API-Mn(II)@HA NPs) exhibited a diameter of 200 nm and were effective against UC. The preparation of the API-Mn(II) complex was relatively simple, and the mechanism underlying its therapeutic effect on UC induced by sodium dextran sulfate (DSS) was studied in detail. We found that API-Mn(II)@HA nanoparticles could effectively repair the intestinal barrier and significantly improve the damaged colon tissue by mediating inflammatory factors. This study provides novel insights on a new kind of active targeted nanoparticle for improving the efficacy of drugs for UC treatment.Keywords
Funding Information
- National Natural Science Foundation of China
- Natural Science Foundation of Shaanxi Province
This publication has 19 references indexed in Scilit:
- Self‐Assembly of Multi‐nanozymes to Mimic an Intracellular Antioxidant Defense SystemAngewandte Chemie, 2016
- Self‐Assembly of Multi‐nanozymes to Mimic an Intracellular Antioxidant Defense SystemAngewandte Chemie International Edition, 2016
- Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathwaysThe Journal of Nutritional Biochemistry, 2016
- Novel Targets for Inflammatory Bowel Disease TherapeuticsCurrent Gastroenterology Reports, 2013
- VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitisMolecular and Cellular Biochemistry, 2012
- Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosaJournal of Controlled Release, 2012
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewGastroenterology, 2012
- Use of apigenin from Cordia dichotoma in the treatment of colitisFitoterapia, 2011
- Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and FisetinInternational Immunopharmacology, 2011
- Nanoparticles Enhance Therapeutic Efficiency by Selectively Increased Local Drug Dose in Experimental Colitis in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2005